Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 3

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 3
---
. We will, however, receive the proceeds from any cash exercises of Warrants.

Our common stock is listed
on The Nasdaq Capital Market (“Nasdaq”) under the symbol “NDRA”. On November 5, 2025, the last reported
sale price of our common stock on Nasdaq was $5.205 per share.

Investing in our common stock involves a high degree of risk. Please read the information contained in and incorporated by reference under the heading “Risk Factors” beginning on page 5 of this prospectus and the risk factors described in the documents that are incorporated by reference into this prospectus, as they may be amended, updated or modified periodically in our reports filed with the Securities and Exchange Commission.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025

TABLE OF CONTENTS</div>

|                                                      | Page |
| ABOUT THIS PROSPECTUS                                |   ii |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS |  iii |
| PROSPECTUS SUMMARY                                   |    1 |
| RISK FACTORS                                         |    5 |
| USE OF PROCEEDS                                      |   14 |
| DESCRIPTION OF CAPITAL STOCK                         |   14 |
| SELLING STOCKHOLDERS                                 |   17 |
| DIVIDEND POLICY                                      |   19 |
| PLAN OF DISTRIBUTION                                 |   19 |
| LEGAL MATTERS                                        |   21 |
| EXPERTS                                              |   21 |
| WHERE YOU CAN FIND MORE INFORMATION                  |   21 |
| INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE      |   21 |

We have not, nor has any selling stockholder, authorized any dealer, salesperson or other person to give any information or to make any representation other than those contained in or incorporated by reference into this prospectus or any applicable free writing prospectus. You must not rely upon any information or representation not contained in or incorporated by reference into this prospectus or any applicable free writing prospectus as if we had authorized it. This prospectus and any applicable free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does